Multivariate analysis of survival in inflammatory breast cancer: impact of intensity of chemotherapy in multimodality treatment
- 8 March 2004
- journal article
- Published by Springer Nature in Bone Marrow Transplantation
- Vol. 33 (9), 913-920
- https://doi.org/10.1038/sj.bmt.1704458
Abstract
No abstract availableKeywords
This publication has 38 references indexed in Scilit:
- Distinct and Complementary Information Provided by Use of Tissue and DNA Microarrays in the Study of Breast Tumor MarkersThe American Journal of Pathology, 2002
- First-line high-dose sequential chemotherapy with rG-CSF and repeated blood stem cell transplantation in untreated inflammatory breast cancer: toxicity and response (PEGASE 02 trial)British Journal of Cancer, 1999
- Inflammatory breast carcinoma incidence and survivalCancer, 1998
- Combined Modality Treatment of Stage III and Inflammatory Breast CancerSurgical Oncology Clinics of North America, 1995
- Lenograstim prevents morbidity from intensive induction chemotherapy in the treatment of inflammatory breast cancer.Journal of Clinical Oncology, 1995
- Prognostic factors in inflammatory breast cancer and therapeutic implicationsEuropean Journal Of Cancer, 1994
- Two distinct mechanisms alter p53 in breast cancer: mutation and nuclear exclusion.Proceedings of the National Academy of Sciences, 1992
- Inflammatory breast cancer: a review.Journal of Clinical Oncology, 1992
- Results of initial doxorubicin, 5-fluorouracil, and cyclophosphamide combination chemotherapy for inflammatory carcinoma of the breastCancer, 1990
- Structure and expression of c‐erbB‐2 and EGF receptor genes in inflammatory and non‐inflammatory breast cancer: Prognostic significanceInternational Journal of Cancer, 1989